Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
My Top 5 Stocks to Buy in Early 2026
04:15am, Wednesday, 07'th Jan 2026
These stocks, ranging from technology to healthcare, could add diversification to your portfolio. Four have proven their earnings strength; the fifth makes a solid recovery story bet.
Kellanova (NYSE:K) Shares Unloaded Sen. Shelley Moore Capito
02:02am, Wednesday, 07'th Jan 2026
Senator Shelley Moore Capito (R-West Virginia) recently sold shares of Kellanova (NYSE: K). In a filing disclosed on January 06th, the Senator disclosed that they had sold between $1,001 and $15,000 i
Sen. Shelley Moore Capito Sells Off Shares of Apple Inc. (NASDAQ:AAPL)
02:02am, Wednesday, 07'th Jan 2026
Senator Shelley Moore Capito (R-West Virginia) recently sold shares of Apple Inc. (NASDAQ: AAPL). In a filing disclosed on January 06th, the Senator disclosed that they had sold between $1,001 and $15
Ventyx (VTYX) Shares Soar 62.5% Overnight, Here's What's Going On With This Trending Stock
10:14pm, Tuesday, 06'th Jan 2026
Ventyx shares jumped in after-hours trading following reports that Eli Lilly is in advanced talks to acquire the biopharma company for over $1 billion.
Market Today: Records, robots, obesity pill, and AI tie-ups
05:35pm, Tuesday, 06'th Jan 2026
Stock News Regulators press X over Grok deepfakes: UK authorities and EU officials demanded action after reports that X's Grok chatbot generated nonâconsensua
Eli Lilly's 2026 Resolution: Volume Is The New Price
04:56pm, Tuesday, 06'th Jan 2026
Eli Lilly and Company remains a Buy, supported by robust incretin-driven growth and strategic expansion in obesity treatments. LLY pivots from scarcity to access economics, prioritizing volume over ne
Eli Lilly is in advanced talks to acquire Ventyx Biosciences for more than $1 billion, according to people familiar with the matter
03:40pm, Tuesday, 06'th Jan 2026
The more-than-$1 billion deal could come imminently.
Are You Looking for a Top Momentum Pick? Why Eli Lilly (LLY) is a Great Choice
01:01pm, Tuesday, 06'th Jan 2026
Does Eli Lilly (LLY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Eli Lilly, Nimbus Partner to Develop, License Oral Obesity Treatment
12:38pm, Tuesday, 06'th Jan 2026
Eli Lilly and Nimbus Therapeutics have entered into a multiyear collaboration and exclusive licensing agreement to develop an oral treatment for obesity and other metabolic diseases.
Nimbus, Lilly sign deal to develop new oral obesity drug
10:29am, Tuesday, 06'th Jan 2026
Nimbus Therapeutics said on Tuesday it has entered into a multi-year research and licensing agreement with Eli Lilly to develop artificial intelligence-driven new oral treatments for obesity and other
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
10:01am, Tuesday, 06'th Jan 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Should You Buy Eli Lilly Before It Reaches $1 Trillion in Market Value?
09:10am, Tuesday, 06'th Jan 2026
Eli Lilly briefly reached $1 trillion in market cap last year before retreating. The company has seen revenue soar in recent quarters thanks to its weight loss portfolio.
Rede Wealth LLC Buys New Stake in Eli Lilly and Company $LLY
07:30am, Tuesday, 06'th Jan 2026
Rede Wealth LLC bought a new position in shares of Eli Lilly and Company (NYSE: LLY) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commi
Daymark Wealth Partners LLC Purchases 2,119 Shares of Eli Lilly and Company $LLY
06:22am, Tuesday, 06'th Jan 2026
Daymark Wealth Partners LLC lifted its position in shares of Eli Lilly and Company (NYSE: LLY) by 18.8% in the third quarter, according to the company in its most recent disclosure with the Securities
Eli Lilly and Company $LLY Shares Sold by Cynosure Group LLC
06:22am, Tuesday, 06'th Jan 2026
Cynosure Group LLC decreased its stake in shares of Eli Lilly and Company (NYSE: LLY) by 33.1% during the undefined quarter, according to the company in its most recent filing with the Securities and
